1. Modulation of circulating protein biomarkers following TRC105 (anti‐endoglin antibody) treatment in patients with advanced cancer
   Yingmiao Liu et al, 2014, Cancer Medicine CrossRef
2. FGFs: crucial factors that regulate tumour initiation and progression
   Qian Jing et al, 2016, Cell Proliferation CrossRef
3. A potential small-molecule synthetic antilymphangiogenic agent norcantharidin inhibits tumor growth and lymphangiogenesis of human colonic adenocarcinomas through blocking VEGF-A,-C,-D/VEGFR-2,-3 “multi-points priming” mechanisms in vitro and in vivo
   Xin-Ping Li et al, 2015, BMC Cancer CrossRef
4. Matrix Metalloproteinases’ Role in Tumor Microenvironment
   Georgina Gonzalez-Avila et al, 2020, Tumor Microenvironment CrossRef
5. miR-27a induced by colon cancer cells in HLECs promotes lymphangiogenesis by targeting SMAD4
   Qi Xu et al, 2017, PLOS ONE CrossRef